Number of Months With Positive Response for SGA of Relief§
12 mg/d Study 4 mg/d (4-12 mg/d)
B351 Original SGA of relief .107 .047
B351 SGA of relief .353 .013*
B301 SGA of relief .008* < .001*
B307 SGA of relief .479 .008*
* Statistically significant with adjustment for multiple comparisons.
§ Primary analysis of alosetron data. Gastrointestinal Drug Advisory Committee meeting, November 16, 1999.